Medication review company Ward MM has announced a world first model of care called Thrive – a new service that provides individuals with personalised medication plans.
The aim of the Thrive is to reduce the risks of harm caused by taking multiple medications through DNA analysis, collaboration with an individual’s health care team, and working with clinical pharmacists specialising in geriatric medicine.
With more than 66 per cent of Australians aged 75-plus taking five or more medications every day, the need for a service like Thrive has never been more prevalent, according to the head of clinical development Natalie Soulsby.
“Clinical pharmacists are the communication between all areas of healthcare for the patients and we support the right drugs for the right reasons,” Soulsby said.
She said the Thrive concept would work in a holistic way for those living in aged care facilities.
It starts by having a conversation with the individual and their families. A consultation plan is then devised in conjunction with DNA testing.
“We then talk to their GP and come up with the action plan over a long period of time. We make changes slowly. We then have follow ups, so it’s a cyclical process,” she explained.
She said it was imperative that the carers involved with the residents were aware of the process and that the residents had access to their personal plan.
Aged Care Insite spoke with Soulsby to learn more.Do you have an idea for a story?
Email [email protected]